Nivolumab
CA209-651
Phase 3 mab completed
Quick answer
Nivolumab for Head and Neck Cancer is a Phase 3 program (mab) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Head and Neck Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed